Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 464 participants.
Also called NCT04200781
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 464 participants
- Sponsor
- ShuGuang Hospital
- Registry
-
NCT04200781
-
- Other papers using this trial's data
- Treatment of acute intracerebral haemorrhage with a Chinese herbal formula (Shengdi Dahuang Decoction): a multicentre, double-blind, randomised, placebo-controlled trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04200781. Randomized; double masking; primary purpose treatment. Start 2019-09-01 (actual); primary completion 2022-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
- Condition
- Hemorrhagic Stroke
- Intervention (Drug)
- Granules of Shengdi Dahuang Decoction
- Intervention (Drug)
- Placebo
- Lead sponsor
- ShuGuang Hospital
Record details
- Record id
cardio:ct-nct04200781- Content hash
457b82583c61c5442b296fb43e384198f2633ced0d205c02ca99c3b54886c09f